CAR T cells are patient-derived, genetically engineered immune cells. They are "living drugs" and constitute a milestone in ...

Researchers from Mass General Brigham and the Broad Institute of MIT and Harvard have identified genetic modifications that ...

Over the past few decades, biomedical researchers and neuroscientists have devised increasingly advanced techniques to study ...

Researchers from Mass General Brigham and the Broad Institute of MIT and Harvard have identified genetic modifications that can improve the efficacy ...

A new study published in JCO Precision Oncology has identified a relatively simple method to predict the cancer patients most likely to develop severe toxicities from chemotherapy. If doctors can ...

PacBio enters the high-throughput carrier screening market with a standalone HiFi sequencing assay for challenging genes.

Two studies published today in the American Journal of Human Genetics show the potential for genomic screening in newborns to address high rates of infant hospitalization and mortality in the United ...

Please provide your email address to receive an email when new articles are posted on . Digital screening improved identification of patients meeting hereditary risk assessment guidelines. Patient ...

Routine genetic testing for maturity-onset diabetes of the young (MODY) could be cost-effective or even save money, depending on the price of the test and the prevalence of MODY in the population ...

PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced its entry into the high-throughput carrier screening market with a significantly ...

LONDON, United Kingdom — Newly identified genetic variants could revolutionize cancer screening by distinguishing people at highest risk for certain cancers from people at lowest risk. The largest ...

The Family Heart Foundation , a leading research and advocacy organization, announced the online publication of ...